Dna X (SONM) Receivables (2018 - 2025)
Historic Receivables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $16.0 million.
- Dna X's Receivables rose 6779.96% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 6779.96%. This contributed to the annual value of $14.0 million for FY2024, which is 4714.93% down from last year.
- Dna X's Receivables amounted to $16.0 million in Q3 2025, which was up 6779.96% from $9.8 million recorded in Q2 2025.
- Dna X's Receivables' 5-year high stood at $33.6 million during Q3 2023, with a 5-year trough of $5.6 million in Q3 2021.
- Over the past 5 years, Dna X's median Receivables value was $15.2 million (recorded in 2024), while the average stood at $16.5 million.
- As far as peak fluctuations go, Dna X's Receivables skyrocketed by 26506.64% in 2023, and later plummeted by 7154.84% in 2024.
- Quarter analysis of 5 years shows Dna X's Receivables stood at $15.3 million in 2021, then skyrocketed by 61.31% to $24.7 million in 2022, then grew by 7.43% to $26.5 million in 2023, then tumbled by 47.15% to $14.0 million in 2024, then grew by 14.4% to $16.0 million in 2025.
- Its Receivables stands at $16.0 million for Q3 2025, versus $9.8 million for Q2 2025 and $14.0 million for Q1 2025.